Hs-Troponin T Kinetics in Patients Treated With MCO Membranes Compared to High-flux, Low-flux Membranes and HDF

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
In this study, 24 prevalent hemodialysis patients will undergo four regular hemodialysis sessions during which four different treatments will be performed. * Treatment 1: MCO membrane (=medium cut off) * Treatment 2: low flux membrane * Treatment 3: high flux membrane * Treatment 4: HDF(=hemodiafiltration) treatment with high flux membrane So far, there is no data on cardiac bioenzyme levels during hemodialysis on the MCO membrane, thus, a acute elevation during hemodialysis might be mitigated by increased clearance.
Epistemonikos ID: c9386f05a5cc4c189fe378d77db8dc88d9b9e8be
First added on: May 13, 2024